HME Amino Acid Supplementation for Strength, Performance, and Recovery in Trained Adult Males
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-45
SponsorOrivian inc
About this trial
This pilot randomized controlled trial evaluates HME (Human Muscle Equivalent), a free-form amino acid supplement formulated to match the amino acid composition of human skeletal muscle, taken at its Health Canada licensed dose (3 g powder plus one 50 mg slow-release beta-alanine capsule daily). Trained adult males (competitive athletes or certified fitness professionals) are randomized to HME or an identical-appearing placebo for 10 weeks: a 2-week supplement-only lead-in followed by 8 weeks of supplement plus supervised resistance training. The primary aim is to estimate the effect of HME on composite maximal strength (1-repetition maximum leg press plus chest press) compared with placebo. Secondary measures include isometric knee-extension strength, countermovement jump height, and subjective recovery.
Eligibility criteria
Qualifiers
Age 18 to 45 years inclusive
Biological male
Active competitive athlete in a recognized sport OR certified fitness professional (personal trainer, strength and conditioning coach, or equivalent)
Minimum 3 structured resistance-training sessions per week for at least 1 year continuously
Disqualifiers
Use of anabolic steroids, SARMs, prohormones, or beta-alanine supplements (other than the study product) within 8 weeks of screening
Current use of any amino acid supplement or weight-gainer product not cleared by the research coordinator
Currently in an active competitive season with non-negotiable training demands the investigator determines are incompatible with the supervised programme
Musculoskeletal injury in the preceding 3 months affecting ability to perform study assessments or training
Trial design
Treatments tested in this trial
- HME (Human Muscle Equivalent)
- Placebo
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov